Enzymatica

Enzymatica is a life science company with the business concept of providing effective help for some of the most common diseases where viruses or bacteria play a decisive role. In a short period, the company has developed a unique oral spray for colds, ColdZyme®, and launched it in six markets. Since its introduction, the product has become one of the leading cold remedies in Swedish pharmacies. The company develops medical devices for upper respiratory tract infections and oral health, as well as veterinary products. Headquartered in Lund, Sweden, the company is listed on Nasdaq First North.